Instrument Inactif

Autres langues Quest PharmaTech Inc Toronto S.E.

Actions

QPT

CA74836M1068

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Quest PharmaTech Inc. Reports Earnings Results for the First Quarter Ended April 30, 2024	28/06
Quest PharmaTech Announces Filing of 2024 Year End Financial Statements and Restated Fiscal 2023 Financial Statements, and Appointment of New Director	30/05
Quest Pharmatech Inc. Announces the Appointment of Bradley J. Glass to the Board of Directors	30/05
Quest PharmaTech Inc. Reports Earnings Results for the Full Year Ended January 31, 2024	29/05
Quest PharmaTech Brief: Says Quest has a 42.5% ownership interest in OncoQuest; Adds dividend income will be used by Quest for general corporate purposes	30/01
Quest PharmaTech Brief: Received a cash dividend payment from OncoQuest Inc. of approximately C$685,000	30/01
Quest Receives Cash Dividend Payment from OncoQuest	30/01
Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis	24/01
Quest PharmaTech Inc. - Oregovomab Phase III Clinical Study fails futility analysis, Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits	24/01
Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits	23/01
Quest PharmaTech Inc. Receives Recommendations from the Data Safety Monitoring Board to Discontinue Oregovomab Phase III Clinical Study	23/01
Quest PharmaTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	13/12
Quest PharmaTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	21/09/23
Quest PharmaTech Provides Corporate Update	13/09/23
Quest PharmaTech Announces Results from AGM	14/07/23
Quest PharmaTech Provided Product Development Update	10/07/23
Quest PharmaTech Provides Product Development Update	10/07/23
Quest PharmaTech Inc. Provides Product Development Update	10/07/23
Quest PharmaTech Inc. Reports Earnings Results for the First Quarter Ended April 30, 2023	29/06/23
Quest PharmaTech Provides Corporate Update	09/06/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Quest PharmaTech Inc Toronto S.E.

Actions

QPT

CA74836M1068

Autres langues

Filtres